Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Chang

Showing results (1041-1050 of 1,110) with videos related to

Pageof 111
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 25, 2019
Incidence, Risk Factors, Outcomes, and Risk Score Model of Acute Pancreatitis after Allogeneic Hematopoietic Stem Cell TransplantationXing-Lin Wang, Wei Han, Peng Zhao, et al.
British Journal of Haematology|May 26, 2025
Prognostic value of CEBPA bZIP signatures in cytogenetically normal acute myeloid leukaemiaLi-Xin Wu, Ming-Yue Liao, Ming-Yue Zhao, et al.
Journal of Hematology & Oncology|March 20, 2019
Early myeloid-derived suppressor cells (HLA-DR<sup>-</sup>/<sup>low</sup>CD33<sup>+</sup>CD16<sup>-</sup>) expanded by granulocyte colony-stimulating factor prevent acute graft-versus-host disease (GVHD) in humanized mouse and might contribute to lower GVHD in patients post allo-HSCTKe Wang, Meng Lv, Ying-Jun Chang, et al.
Frontiers in Oncology|January 24, 2022
Preemptive Immunotherapy for Minimal Residual Disease in Patients With t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell TransplantationShuang Fan, Meng-Zhu Shen, Xiao-Hui Zhang, et al.
Bone Marrow Transplantation|August 22, 2018
The significance of peri-transplantation minimal residual disease assessed by multiparameter flow cytometry on outcomes for adult AML patients receiving haploidentical allograftsJing Liu, Rui Ma, Yan-Rong Liu, et al.
Annals of Hematology|May 28, 2020
Comparison of central nervous system relapse outcomes following haploidentical vs identical-sibling transplant for acute lymphoblastic leukemiaQi Chen, Xin Zhao, Hai-Xia Fu, et al.
Blood|October 19, 2021
All-trans retinoic acid plus low-dose rituximab vs low-dose rituximab in corticosteroid-resistant or relapsed ITPYe-Jun Wu, Hui Liu, Qiao-Zhu Zeng, et al.
Science Advances|January 21, 2022
In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapyJeong Pil Han, MinJeong Kim, Beom Seok Choi, et al.
Blood Advances|May 5, 2019
Dysregulated megakaryocyte distribution associated with nestin<sup>+</sup> mesenchymal stem cells in immune thrombocytopeniaMin Wang, Ru Feng, Jia-Min Zhang, et al.
Biomolecules & Biomedicine|May 15, 2023
CSRP2 transcript levels after consolidation therapy increase prognostic prediction ability in B-cell acute lymphoblastic leukaemiaLei-Ming Cao, Ya-Lan Zhou, Robert Peter Gale, et al.
Pageof 111

Showing results (1041-1050 of 1,110) with videos related to

Sort By:
Pageof 111
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 25, 2019
Incidence, Risk Factors, Outcomes, and Risk Score Model of Acute Pancreatitis after Allogeneic Hematopoietic Stem Cell TransplantationXing-Lin Wang, Wei Han, Peng Zhao, et al.
British Journal of Haematology|May 26, 2025
Prognostic value of CEBPA bZIP signatures in cytogenetically normal acute myeloid leukaemiaLi-Xin Wu, Ming-Yue Liao, Ming-Yue Zhao, et al.
Journal of Hematology & Oncology|March 20, 2019
Early myeloid-derived suppressor cells (HLA-DR<sup>-</sup>/<sup>low</sup>CD33<sup>+</sup>CD16<sup>-</sup>) expanded by granulocyte colony-stimulating factor prevent acute graft-versus-host disease (GVHD) in humanized mouse and might contribute to lower GVHD in patients post allo-HSCTKe Wang, Meng Lv, Ying-Jun Chang, et al.
Frontiers in Oncology|January 24, 2022
Preemptive Immunotherapy for Minimal Residual Disease in Patients With t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell TransplantationShuang Fan, Meng-Zhu Shen, Xiao-Hui Zhang, et al.
Bone Marrow Transplantation|August 22, 2018
The significance of peri-transplantation minimal residual disease assessed by multiparameter flow cytometry on outcomes for adult AML patients receiving haploidentical allograftsJing Liu, Rui Ma, Yan-Rong Liu, et al.
Annals of Hematology|May 28, 2020
Comparison of central nervous system relapse outcomes following haploidentical vs identical-sibling transplant for acute lymphoblastic leukemiaQi Chen, Xin Zhao, Hai-Xia Fu, et al.
Blood|October 19, 2021
All-trans retinoic acid plus low-dose rituximab vs low-dose rituximab in corticosteroid-resistant or relapsed ITPYe-Jun Wu, Hui Liu, Qiao-Zhu Zeng, et al.
Science Advances|January 21, 2022
In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapyJeong Pil Han, MinJeong Kim, Beom Seok Choi, et al.
Blood Advances|May 5, 2019
Dysregulated megakaryocyte distribution associated with nestin<sup>+</sup> mesenchymal stem cells in immune thrombocytopeniaMin Wang, Ru Feng, Jia-Min Zhang, et al.
Biomolecules & Biomedicine|May 15, 2023
CSRP2 transcript levels after consolidation therapy increase prognostic prediction ability in B-cell acute lymphoblastic leukaemiaLei-Ming Cao, Ya-Lan Zhou, Robert Peter Gale, et al.
Pageof 111